What is Evommune 's operating lease liabilities (current)?

Evommune (EVMN) reported operating lease liabilities (current) of $375.48K in Q1 2026.

What is the long-term trend for Evommune 's operating lease liabilities (current)?

Over 2 years (2023 to 2025), Evommune 's operating lease liabilities (current) has grown at a -60.6% compound annual growth rate (CAGR), from $2.4M to $371.27K.

What does operating lease liabilities (current) mean?

The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Evommune EVMN Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Bausch + LombBLCO

$38M+18.8%

BillionToOne, Inc. BLLN

$5.82M—

Perrigo CompanyPRGO

$26.1M-5.1%

Hims & Hers HealthHIMS

$5.58M+49.3%

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's operating lease liabilities (current)?: Evommune (EVMN) reported operating lease liabilities (current) of $375.48K in Q1 2026.
What is the long-term trend for Evommune 's operating lease liabilities (current)?: Over 2 years (2023 to 2025), Evommune 's operating lease liabilities (current) has grown at a -60.6% compound annual growth rate (CAGR), from $2.4M to $371.27K.
What does operating lease liabilities (current) mean?: The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.